CAS 89197-00-2

Efaroxan hydrochloride

CAS: 89197-00-2

Formel: C₁₃H₁₇ClN₂O

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 252.7399

Ref: IN-DA003VPE

Efaroxan hydrochloride

CAS: 89197-00-2

Efaroxan hydrochloride

Reinheit: ≥95%

Molekulargewicht: 252.74g/mol

Ref: 54-BUP21739

Efaroxan hydrochloride

CAS: 89197-00-2

Formel: C₁₃H₁₆N₂O·HCl

Molekulargewicht: 252.74

Ref: 7W-GL0864

2-(2-ETHYL-2,3-DIHYDROBENZOFURAN-2-YL)-4,5-DIHYDRO-1H-IMIDAZOLE HCL

CAS: 89197-00-2

Reinheit: 98.0%

Molekulargewicht: 252.74000549316406

Ref: 10-F534952

Efaroxan hydrochloride

CAS: 89197-00-2

Efaroxan hydrochloride is a cyclase inhibitor that blocks imidazoline receptors. It has been shown to prevent body formation in the model system and reduce food intake in rats. This drug also prevents the release of insulin from pancreatic beta cells, which leads to reduced glucose levels. Efaroxan hydrochloride has been shown to stimulate the activity of agmatine, an endogenous amino acid neurotransmitter, by blocking its reuptake. Agmatine has been shown to have a hypoglycemic effect in animal models. The drug may also have negative effects on the kidneys as it causes increased levels of cytosolic Ca2+ ions. Efaroxan hydrochloride can be used for treating disorders of the central nervous system such as Parkinson disease and depression. However, this drug should not be taken with other drugs that affect serotonin levels because it can lead to serotonin syndrome, which is characterized by high fever, hyperthermia, rigidity, autonomic instability (

Formel: C₁₃H₁₆N₂O·HCl

Reinheit: Min. 95%

Molekulargewicht: 252.74 g/mol

Ref: 3D-PDA19700

Efaroxan hydrochloride

CAS: 89197-00-2

Efaroxan hydrochloride a selective, oral α2-adrenoceptor antagonist significantly potentiates adrenaline-induced increases in insulin levels.

Formel: C₁₃H₁₇ClN₂O

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 252.74

Ref: TM-T22760